Forecasting Seizures Using Intelligent Wearable Technology for Health Tracking
ConditionEpilepsy; Seizure
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age6+
SponsorEmpatica, Inc.
About this trial
The goal of this interventional study is to develop a personalized seizure risk forecast tool in people with epilepsy.
The main questions it aims to answer are:
* can we develop a future seizure probabilities tool that is more accurate than chance based on the pattern and frequency of previous generalized tonic-clonic seizure (GTCS) events, as well as changes in physiological and behavioral variables. * does this tool improve the lives of people with epilepsy?
Researchers will compare a group that does not have access to the forecast tool to a group that does and see if it is accurate and if people with it report that it improved their quality of life.
Eligibility criteria
Qualifiers
Subjects must be diagnosed with or be at risk of epilepsy
Subjects or their parents or guardians must understand and consent to be in the study;
Subjects or their parents or guardians must be able to read and communicate in English;
Subjects or their parents or guardians must be willing and able to comply with study procedures and duration;
Disqualifiers
Subjects, or their parents or guardians for minor study participants, who do not understand the study and the risks;
Subjects, or their parents or guardians for minor study participants, who are either physically or cognitively incapable of performing study activities (e.g. filling in surveys and daily e-diary);
Subjects who would be placed at undue medical risk associated with any procedure called for in the protocol; or
Subjects that are Empatica employees and actively participated in the development of this protocol or development of the Seizure Wise algorithms.
Trial design
Treatments tested in this trial
- SeizureWise algorithm
- Multi-day Visualizations
Treatment groups
3,000 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov